2.13 – Antineoplastic drugs

[1]  N. Oo,et al.  Non-Hodgkin's lymphoma in pregnancy. , 2010, Asia-Oceania journal of obstetrics and gynaecology.

[2]  Tadao Tanaka,et al.  Adjuvant Chemotherapy in a Pregnant Woman With Endodermal Sinus Tumor of the Ovary , 2007, Obstetrics and gynecology.

[3]  C. Bosetti,et al.  Female survivors of childhood cancer: preterm birth and low birth weight among their children. , 2006, Journal of the National Cancer Institute.

[4]  G. Hortobagyi,et al.  Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero , 2006, Cancer.

[5]  C. Rochlitz,et al.  Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. , 2006, The Lancet. Oncology.

[6]  R. Casper,et al.  Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. , 2006, Fertility and sterility.

[7]  G. Burton,et al.  Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. , 2006, Clinical breast cancer.

[8]  B. Drénou,et al.  Administration of rituximab during the first trimester of pregnancy without consequences for the newborn , 2006, Journal of Perinatology.

[9]  M. Clemons,et al.  Breast cancer in pregnancy: are taxanes safe? , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[10]  L. Lagae,et al.  Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature , 2004, International Journal of Gynecologic Cancer.

[11]  H. Kantarjian,et al.  Pregnancy among patients with chronic myeloid leukemia treated with imatinib. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Y. Nieto,et al.  Docetaxel administered during pregnancy for inflammatory breast carcinoma. , 2006, Clinical breast cancer.

[13]  M. Shaheed,et al.  A case of methotrexate embryopathy with holoprosencephaly, expanding the phenotype. , 2006, Birth defects research. Part A, Clinical and molecular teratology.

[14]  J. Graham,et al.  Effect of adjuvant trastuzumab on pregnancy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  K. Prabhash,et al.  Pregnancy outcome of two patients treated with imatinib. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  R. Theriault,et al.  Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. , 2005, Clinical breast cancer.

[17]  C. Kawakami,et al.  Plasma All-Trans Retinoic Acid Level in Neonates of Mothers with Acute Promyelocytic Leukemia , 2005, Acta Haematologica.

[18]  R. Rosa,et al.  Combined chemotherapy and teratogenicity. , 2005, Birth defects research. Part A, Clinical and molecular teratology.

[19]  J. Rowe,et al.  Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma. , 2005, Human reproduction.

[20]  T. Yakut,et al.  Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission. , 2005, Leukemia research.

[21]  P. Hall,et al.  Treatment of Acute Myeloid Leukemia During the Second and Third Trimesters of Pregnancy , 2005, Pharmacotherapy.

[22]  L. Magder,et al.  Cyclophosphamide for lupus during pregnancy , 2005, Lupus.

[23]  P. Ellis,et al.  Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  A. Pathare,et al.  Successful outcome with anagrelide in pregnancy , 2005, Annals of Hematology.

[25]  A. Pathare,et al.  Imatinib in pregnancy , 2005, European journal of haematology.

[26]  G. Scambia,et al.  Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review. , 2005, Gynecologic oncology.

[27]  P. Whitecar,et al.  Anomalies Associated With Failed Methotrexate and Misoprostol Termination , 2005, Obstetrics and gynecology.

[28]  Chong-Taik Park,et al.  Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases. , 2005, Reproductive toxicology.

[29]  J. Kerr.  Neonatal Effects of Breast Cancer Chemotherapy Administered During Pregnancy , 2005, Pharmacotherapy.

[30]  W. Watson.  Herceptin (Trastuzumab) Therapy During Pregnancy: Association With Reversible Anhydramnios , 2005, Obstetrics and gynecology.

[31]  A. V. van Bodegraven,et al.  6-Thioguanine for Crohn's disease during pregnancy: Thiopurine metabolite measurements in both mother and child , 2005, Scandinavian journal of gastroenterology.

[32]  D. Mouratidou,et al.  Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer. , 2004, Gynecologic oncology.

[33]  M. Ross,et al.  Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. , 2004, Clinical breast cancer.

[34]  John D Boice,et al.  Genetic effects of radiotherapy for childhood cancer: gonadal dose reconstruction. , 2004, International journal of radiation oncology, biology, physics.

[35]  P. Janků,et al.  Anagrelide therapy in pregnancy: report of a case of essential thrombocythemia , 2004, Annals of Hematology.

[36]  R. Clark,et al.  Successful Outcome of Pregnancy in Chronic Myeloid Leukaemia Treated with Imatinib , 2004, Leukemia & lymphoma.

[37]  A. Ishida,et al.  Good outcome for infant of mother treated with chemotherapy for ewing sarcoma at 25 to 30 weeks' gestation. , 2004, Journal of pediatric hematology/oncology.

[38]  E. Cardonick,et al.  Use of chemotherapy during human pregnancy. , 2004, The Lancet. Oncology.

[39]  E. Kimby,et al.  Safety of rituximab therapy during the first trimester of pregnancy: a case history , 2004, European journal of haematology.

[40]  C. Pata,et al.  Polycythemia Vera and Pregnancy: A Case Report with the Use of Hydroxyurea in the First Trimester , 2004, American journal of perinatology.

[41]  C. Bodian,et al.  The Effect on the Fetus of Medications Used to Treat Pregnant Inflammatory Bowel-Disease Patients , 2004, American Journal of Gastroenterology.

[42]  M. D'armiento,et al.  Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancy. , 2004, Birth defects research. Part A, Clinical and molecular teratology.

[43]  H. Hoyme,et al.  Methotrexate/misoprostol embryopathy: Report of four cases resulting from failed medical abortion , 2003, American journal of medical genetics. Part A.

[44]  V. González-Quintero,et al.  Paclitaxel and Carboplatin Chemotherapy Administered During Pregnancy for Advanced Epithelial Ovarian Cancer , 2003, Obstetrics and gynecology.

[45]  J. Olsen,et al.  GENETIC EFFECTS OF RADIOTHERAPY FOR CHILDHOOD CANCER , 2003, Health physics.

[46]  K. Jones,et al.  Cyclophosphamide, methotrexate, and cytarabine embropathy: is apoptosis the common pathway? , 2003, Birth defects research. Part A, Clinical and molecular teratology.

[47]  J. Abramowicz,et al.  Prenatal Diagnosis of Methotrexate Embryopathy , 2003, Obstetrics and gynecology.

[48]  J. Ford,et al.  Imatinib treatment: specific issues related to safety, fertility, and pregnancy. , 2003, Seminars in hematology.

[49]  B. Nørgård,et al.  Azathioprine, mercaptopurine and birth outcome: a population‐based cohort study , 2003, Alimentary pharmacology & therapeutics.

[50]  D. Green,et al.  Pregnancy outcome of partners of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  D. Green,et al.  Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. , 2002, American journal of obstetrics and gynecology.

[52]  P. Ganly,et al.  Successful treatment of acute promyelocytic leukaemia during pregnancy. , 2002, Clinical and laboratory haematology.

[53]  D. Tegay,et al.  6-Mercaptopurine teratogenicity , 2002, Postgraduate medical journal.

[54]  P. Pan,et al.  Doxorubicin-induced cardiomyopathy during pregnancy: three case reports of anesthetic management for cesarean and vaginal delivery in two kyphoscoliotic patients. , 2002, Anesthesiology.

[55]  P. O’meara,et al.  Fetal methotrexate and misoprostol exposure: the past revisited. , 2002, Teratology.

[56]  B. L. Siu,et al.  Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. , 2002, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[57]  R. Chaoui,et al.  In utero first trimester exposure to low‐dose methotrexate with increased fetal nuchal translucency and associated malformations , 2002, Prenatal diagnosis.

[58]  J. Friedman,et al.  Teratogen update: azathioprine and 6-mercaptopurine. , 2002, Teratology.

[59]  K. Blakemore,et al.  Multiple Anomalies in a Fetus Exposed to Low‐Dose Methotrexate in the First Trimester , 2002, Obstetrics and gynecology.

[60]  P. Ferns,et al.  Pregnancy outcomes following treatment of cancer , 2002, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[61]  A. Sood,et al.  Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. , 2001, Gynecologic oncology.

[62]  L. Schuler‐Faccini,et al.  Assessment of fetal risk associated with exposure to cancer chemotherapy during pregnancy: a multicenter study. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[63]  G. Koren,et al.  Neurodevelopment of children exposed in utero to treatment of maternal malignancy , 2001, British Journal of Cancer.

[64]  A. Yücel,et al.  Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy , 2001, Lupus.

[65]  M. Jamil,et al.  Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid , 2001, Leukemia.

[66]  C. Thauvin-Robinet,et al.  Exposure to hydroxyurea during pregnancy: a case series , 2001, Leukemia.

[67]  A. Tefferi,et al.  A single institutional experience with 43 pregnancies in essential thrombocythemia , 2001, European journal of haematology.

[68]  K. Clark,et al.  Tamoxifen as systemic treatment of advanced breast cancer during pregnancy--case report and literature review. , 2001, Gynecologic oncology.

[69]  A. Tefferi,et al.  Acute Leukemia during Pregnancy: A Single Institutional Experience with 17 Cases , 2001, Leukemia & lymphoma.

[70]  M. D. De Santis,et al.  Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. , 2000, European journal of cancer care.

[71]  C. Achtari,et al.  Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. , 2000, American journal of obstetrics and gynecology.

[72]  E. Hatzidaki,et al.  Multimodal cancer chemotherapy during the first and second trimester of pregnancy: a case report. , 2000, European journal of obstetrics, gynecology, and reproductive biology.

[73]  D. Byrd,et al.  Hydroxyurea in Two Pregnant Women with Sickle Cell Anemia , 1999, Pharmacotherapy.

[74]  P. Giacalone,et al.  Chemotherapy for breast carcinoma during pregnancy , 1999 .

[75]  E. Roeder,et al.  Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype? , 1999, American journal of medical genetics.

[76]  K. Jones,et al.  Developmental delay in fetal aminopterin/methotrexate syndrome. , 1999, Teratology.

[77]  A. Cesne,et al.  Management of cancer in pregnancy: a case of Ewing's sarcoma of the pelvis in the third trimester. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[78]  D. L. Berry,et al.  Management of breast cancer during pregnancy using a standardized protocol. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[79]  G. Koren,et al.  Hydroxyurea use during pregnancy: A case report in sickle cell disease and review of the literature , 1999, American journal of hematology.

[80]  B. Semmekrot,et al.  Successful fetal outcome after exposure to idarubicin and cytosine-arabinoside during the second trimester of pregnancy--a case report. , 1998, American journal of perinatology.

[81]  E. Bawle,et al.  Adult and two children with fetal methotrexate syndrome. , 1998, Teratology.

[82]  T. Ravikumar,et al.  Chemotherapy for metastatic melanoma during pregnancy. , 1997, Gynecologic oncology.

[83]  A. Shanberg,et al.  Ambiguous genitalia in infant exposed to tamoxifen in utero , 1997, The Lancet.

[84]  J. Curran,et al.  Wegener's granulomatosis in pregnancy. , 1997, Arthritis and rheumatism.

[85]  L. Buckley,et al.  Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. , 1997, Arthritis and rheumatism.

[86]  A. Yajima,et al.  Fetal arrhythmia during treatment of pregnancy-associated acute promtelocytic leukemia with all-trans retinoic acid and favorable outcome , 1997, Leukemia.

[87]  O. Rousseau,et al.  Cis‐platinum neoadjuvant chemotherapy in a pregnant woman with invasive carcinoma of the uterine cervix , 1996, British journal of obstetrics and gynaecology.

[88]  T. Steck,et al.  Eclampsia after polychemotherapy for nodal-positive breast cancer during pregnancy. , 1996, European journal of obstetrics, gynecology, and reproductive biology.

[89]  A. Requena,et al.  Acute leukemia during pregnancy: obstetric management and perinatal outcome of two cases. , 1995, European journal of obstetrics, gynecology, and reproductive biology.

[90]  J. Pons,et al.  Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patient. , 1995, Leukemia & lymphoma.

[91]  T. Kaneko,et al.  Mitoxantrone and etoposide in breast milk , 1995, American journal of hematology.

[92]  D. Acolet,et al.  Fetal marrow suppression after maternal chemotherapy for leukaemia. , 1994, Archives of disease in childhood. Fetal and neonatal edition.

[93]  C. Sutherland,et al.  Goldenhar's syndrome associated with tamoxifen given to the mother during gestation. , 1994, JAMA.

[94]  A. Alothman,et al.  Managing Hairy Cell Leukemia in Pregnancy , 1994, Annals of Internal Medicine.

[95]  S. Hsueh,et al.  Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma , 1994, British journal of obstetrics and gynaecology.

[96]  G. Koren,et al.  Methotrexate exposure prior to and during pregnancy. , 1994, Teratology.

[97]  J. Carey,et al.  Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy. , 1993, Teratology.

[98]  B. Tuch,et al.  Resistance of the Human Fetal P‐Cell to the Toxic Effect of Multiple Low‐Dose Streptozotocin , 1993, Pancreas.

[99]  C. Runowicz,et al.  Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary. , 1993, Gynecologic oncology.

[100]  G. Koren,et al.  Fetal outcome after in utero exposure to cancer chemotherapy. , 1992, Archives of internal medicine.

[101]  A. Avilés,et al.  Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 children , 1991, American journal of hematology.

[102]  J. Sierra,et al.  Pregnancy outcome in hematologic malignancies , 1991, Cancer.

[103]  L. Plouffe,et al.  5-fluorouracil exposure during the period of conception: report on two cases. , 1990, American journal of obstetrics and gynecology.

[104]  A. Avilés,et al.  Non-Hodgkin's lymphomas and pregnancy: presentation of 16 cases. , 1990, Gynecologic oncology.

[105]  A. Mackenzie,et al.  Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. , 1990, The American journal of medicine.

[106]  D. Hémon,et al.  Risk of spontaneous abortion among nurses handling antineoplastic drugs. , 1990, Scandinavian journal of work, environment & health.

[107]  J. Turtle,et al.  Streptozotocin is not toxic to the human fetal B cell , 1989, Diabetologia.

[108]  K. Costeloe,et al.  Transplacental effects of maternal cancer chemotherapy. Case report , 1989, British journal of obstetrics and gynaecology.

[109]  B. Dutrillaux,et al.  Specificity of melphalan-induced rearrangements and their transmission through cell divisions. , 1989, Mutagenesis.

[110]  J. Turchi,et al.  Anthracyclines in the treatment of malignancy in pregnancy , 1988, Cancer.

[111]  J. Feliu,et al.  Acute leukemia and pregnancy , 1988, Cancer.

[112]  C. Clemm,et al.  Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy. , 1987, The New England journal of medicine.

[113]  J. Mulvihill,et al.  Pregnancy outcome in cancer patients. Experience in a large cooperative group , 1987, Cancer.

[114]  F. Shepherd,et al.  Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  J. Reichert,et al.  Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report. , 1984, JAMA.

[116]  A. Chudley,et al.  Successful pregnancy following continuous treatment with combination chemotherapy before conception and throughout pregnancy , 1984, Cancer.

[117]  A. Awidi,et al.  Acute leukemia in pregnancy: report of five cases treated with a combination which included a low dose of adriamycin. , 1983, European journal of cancer & clinical oncology.

[118]  P. Köpf-Maier,et al.  Stage of pregnancy-dependent transplacental passage of 195mPt after cis-platinum treatment. , 1983, European journal of cancer & clinical oncology.

[119]  S. Donaldson,et al.  Management of the pregnant patient with Hodgkin's disease. , 1981, Annals of internal medicine.

[120]  A. L. Borrasca,et al.  Doxorubicin in the first trimester of pregnancy. , 1981, Annals of internal medicine.

[121]  L. Slater,et al.  Successful pregnancy during chemotherapy for acute leukemia , 1981, Cancer.

[122]  A. Schafer.  Teratogenic effects of antileukemic chemotherapy. , 1981, Archives of internal medicine.

[123]  J. Mulvihill,et al.  Pregnancy outcome following cancer chemotherapy. , 1980, The American journal of medicine.

[124]  R. Baehner,et al.  CONGENITAL ABNORMALITIES IN BABY BORN TO CYTARABINE TREATED MOTHER , 1980, The Lancet.

[125]  A. Marchevsky,et al.  Oat cell carcinoma of the uterine cervix in a pregnant woman treated with cis-diamminedichloroplatinum. , 1980, Gynecologic oncology.

[126]  M. Saleem,et al.  ACUTE LEUKÆMIA IN PREGNANCY , 1978, The Lancet.

[127]  J. Lilleyman,et al.  Consequences of acute myelogenous leukemia in early pregnancy , 1977, Cancer.

[128]  M. Peckham,et al.  The investigation and management of Hodgkin's disease in the pregnant patient , 1976, Cancer.

[129]  M. J. Garrett.  Letter: Teratogenic effects of combination chemotherapy. , 1974, Annals of internal medicine.

[130]  R. H. Moser,et al.  Fetal effects during cyclophosphamide and irradiation therapy. , 1971, Annals of internal medicine.

[131]  E. Daw.  Procarbazine in pregnancy. , 1970, Lancet.

[132]  J. Graef,et al.  Methotrexate-induced congenital malformations. , 1968, The Journal of pediatrics.

[133]  H. Nicholson.  CYTOTOXIC DRUGS IN PREGNANCY , 1968 .

[134]  R. Rugh,et al.  RADIATION AND RADIOMIMETRIC CHLORAMBUCIL AND THE FETAL RETINA. , 1965, Archives of ophthalmology.

[135]  H. Fisher,et al.  Pregnancy in Leukaemia , 1965, The Australian & New Zealand journal of obstetrics & gynaecology.

[136]  L. H. Greenberg,et al.  CONGENITAL ANOMALIES PROBABLY INDUCED BY CYCLOPHOSPHAMIDE. , 1964, JAMA.

[137]  I. W. Monie,et al.  POSSIBLE TERATOGENIC EFFECT OF CHLORAMBUCIL ON A HUMAN FETUS. , 1963, JAMA.

[138]  J. Warkany,et al.  Attempted abortion with aminopterin (4-amino-pteroylglutamic acid); malformations of the child. , 1959, A.M.A. journal of diseases of children.

[139]  H. Meltzer.  Congenital anomalies due to attempted abortion with 4-aminopteroglutamic acid. , 1956, Journal of the American Medical Association.

[140]  J. Thiersch.  Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A) administered by the oral route. , 1952, American journal of obstetrics and gynecology.

[141]  G. Alarcón,et al.  Cyclophosphamide use and pregnancy in lupus. , 2006, Lupus.

[142]  V. Choudhry,et al.  Pregnancy on imatinib: fatal outcome with meningocele. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[143]  F. Indelicato,et al.  Acute Promyelocytic Leukemia during Pregnancy: Report of 3 Cases , 2004, International journal of hematology.

[144]  A. Nyfors,et al.  Pharmacokinetics of methotrexate in erythrocytes in psoriasis , 2004, European Journal of Clinical Pharmacology.

[145]  F. Goldwasser,et al.  Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[146]  B. Lambert,et al.  Persistence of chromosome rearrangements in peripheral lymphocytes from patients treated with melphalan for ovarian carcinoma , 2004, Human Genetics.

[147]  C. Bodian,et al.  The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. , 2003, Gastroenterology.

[148]  L. Elit,et al.  An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. , 1999, Gynecologic oncology.

[149]  M. Espié,et al.  Vinorelbine in pregnancy. , 1997, European journal of cancer.

[150]  J. Rodriguez,et al.  VACOP-B chemotherapy for high grade non-Hodgkin's lymphoma in pregnancy. , 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

[151]  G. Koren,et al.  Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. , 1993, Teratogenesis, carcinogenesis, and mutagenesis.

[152]  J. Kopelman,et al.  Inadvertent 5-fluorouracil treatment in early pregnancy: a report of three cases. , 1990, Reproductive toxicology.

[153]  S. Oates.  Non-Hodgkin's lymphoma in pregnancy , 1990 .

[154]  Humphrey Dc,et al.  Normal infant after combination chemotherapy including teniposide for Burkitt's lymphoma in pregnancy. , 1982 .

[155]  J. Rodriguez-Alarcon,et al.  Successful pregnancy in acute promyelocytic leukemia , 1982, Cancer.

[156]  C. Epstein,et al.  Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester. , 1980, American journal of obstetrics and gynecology.

[157]  D. Caldwell,et al.  Renal agenesis after first trimester exposure to chlorambucil. , 1980, Southern medical journal.

[158]  Kouichi R. Tanaka,et al.  Acute leukemia in pregnancy: transient neonatal myelosuppression after combination chemotherapy in the mother. , 1979, Medical and pediatric oncology.